Cargando…
Illuminating luminal B: QSOX1 as a subtype-specific biomarker
Breast cancer is a complex and heterogeneous disease that affects about one out of every eight women. In the last decade, several advancements have been made that have increased our understanding of breast cancer and have allowed us to more accurately diagnose and treat this disease in a more target...
Autores principales: | Das, Padmalaya, Siegers, Gabrielle M, Postovit, Lynne-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706943/ https://www.ncbi.nlm.nih.gov/pubmed/23680167 http://dx.doi.org/10.1186/bcr3417 |
Ejemplares similares
-
Apoptosis Induced via Gamma Delta T Cell Antigen Receptor “Blocking” Antibodies: A Cautionary Tale
por: Dutta, Indrani, et al.
Publicado: (2017) -
Functional Plasticity of Gamma Delta T Cells and Breast Tumor Targets in Hypoxia
por: Siegers, Gabrielle M., et al.
Publicado: (2018) -
Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma
por: Zhou, Lei, et al.
Publicado: (2017) -
QSOX1 Inhibits Autophagic Flux in Breast Cancer Cells
por: Poillet, Laura, et al.
Publicado: (2014) -
Immunohistochemical expression of sulfhydryl oxidase (QSOX1) in pediatric medulloblastomas
por: Sobral, Ana Cristina Lira, et al.
Publicado: (2015)